Imaging With a PET Agent for Detection of Cancers of the Head and Neck

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 10, 2018

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Head and Neck Cancer
Interventions
DRUG

[18F]- PARPi

injection of a microdose (\< 100 ug) of \[18F\]- PARPi

DIAGNOSTIC_TEST

PET/CT Scans

"Patients will be injected with approximately 10 mCi of \[18F\]PARPi and a dynamic PET scan of will be acquired for approximately 30 minutes. A second body PET/CT scan will be started approximately 60 min post injection, and a third PET/CT scan will be started at approximately 120 min post injection. The first (dynamic) and the second (body) PET/CT scan will use ultra -low dose CT scan for attenuation correction. The last PET/CT scan will be performed with the investigator's regular clinical low-dose CT settings."

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT03631017 - Imaging With a PET Agent for Detection of Cancers of the Head and Neck | Biotech Hunter | Biotech Hunter